We are live on
!
Find out more
1CM
1492 Capital Management Portfolio holdings
AUM
$263M
1-Year Est. Return
61.9%
This Fund
S&P 500
This Quarter
Est. Return
-18.23%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$112M
AUM Growth
-$42.1M
(-27%)
Cap. Flow
-$9.44M
Cap. Flow
% of AUM
-8.46%
Top 10 Holdings %
Top 10 Hldgs %
37.03%
Holding
115
New
23
Increased
16
Reduced
44
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Collegium Pharmaceutical
COLL
|
+$2.57M |
| 2 |
Kratos Defense & Security Solutions
KTOS
|
+$2.13M |
| 3 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
+$1.97M |
| 4 |
OptimizeRx
OPRX
|
+$1.96M |
| 5 |
TherapeuticsMD
TXMD
|
+$1.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dycom Industries
DY
|
+$2.89M |
| 2 |
CPE
Callon Petroleum Company
CPE
|
+$2.88M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$2.62M |
| 4 |
ATSG
Air Transport Services Group
ATSG
|
+$2.31M |
| 5 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$2.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.38% |
| 2 | Technology | 25.15% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 6.25% |
| 5 | Financials | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Magnolia Oil & Gas
MGY
$6.09B
| $1.38M | 1.24% |
123,416
+37,017
| +43% | +$466K |
|
27
Korn Ferry
KFY
$4.18B
| $1.33M | 1.19% |
+33,570
| New | +$1.51M |
|
28
ANI Pharmaceuticals
ANIP
$1.8B
| $1.29M | 1.16% |
28,741
-845
| -3% | -$44.3K |
|
29
Ligand Pharmaceuticals
LGND
$5.76B
| $1.2M | 1.07% |
14,146
-1,078
| -7% | -$115K |
|
30
Designer Brands
DBI
$307M
| $1.17M | 1.05% |
+47,464
| New | +$1.27M |
|
31
Euronet Worldwide
EEFT
$2.72B
| $1.14M | 1.03% |
11,173
+3,060
| +38% | +$339K |
|
|
HDP
32
DELISTED
Hortonworks, Inc.
HDP
| $1.06M | 0.95% |
73,336
+7,216
| +11% | +$124K |
|
33
American Eagle Outfitters
AEO
$2.88B
| $1.05M | 0.94% |
54,178
-3,148
| -5% | -$65.5K |
|
34
G-III Apparel Group
GIII
$1.54B
| $973K | 0.87% |
34,882
+23,537
| +207% | +$871K |
|
35
Universal Display
OLED
$3.68B
| $958K | 0.86% |
10,239
-1,740
| -15% | -$176K |
|
|
WNS
36
DELISTED
WNS Holdings
WNS
| $951K | 0.85% |
23,043
-1,660
| -7% | -$79.3K |
|
37
Omnicell
OMCL
$1.61B
| $945K | 0.85% |
15,423
-1,127
| -7% | -$76.3K |
|
|
SYNH
38
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $933K | 0.84% |
23,720
+8,404
| +55% | +$390K |
|
|
BFYT
39
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $894K | 0.8% |
33,435
-6,580
| -16% | -$264K |
|
|
ULTI
40
DELISTED
Ultimate Software Group Inc
ULTI
| $889K | 0.8% |
3,630
-263
| -7% | -$69.7K |
|
|
GRUB
41
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $886K | 0.79% |
5,770
+2,596
| +82% | +$487K |
|
42
Myriad Genetics
MYGN
$270M
| $866K | 0.78% |
29,786
-2,157
| -7% | -$77.6K |
|
|
CTLP
43
DELISTED
Cantaloupe
CTLP
| $847K | 0.76% |
217,808
-9,032
| -4% | -$47.4K |
|
|
HOME
44
DELISTED
At Home Group Inc.
HOME
| $832K | 0.75% |
+44,582
| New | +$1.13M |
|
|
VG
45
DELISTED
Vonage Holdings Corporation
VG
| $766K | 0.69% |
87,709
-6,428
| -7% | -$73.6K |
|
46
Caesars Entertainment
CZR
$6.06B
| $720K | 0.65% |
+19,872
| New | +$789K |
|
47
Cinemark Holdings
CNK
$4.24B
| $716K | 0.64% |
19,998
-1,453
| -7% | -$57.4K |
|
48
World Kinect Corp
WKC
$2.04B
| $715K | 0.64% |
+33,394
| New | +$880K |
|
|
TSG
49
DELISTED
The Stars Group Inc.
TSG
| $711K | 0.64% |
43,044
+14,063
| +49% | +$275K |
|
50
Charles River Laboratories
CRL
$11.2B
| $692K | 0.62% |
6,113
-438
| -7% | -$54.8K |
|
Similar funds
KA
DEA
EAN
PIP
SC
L
LB
ACM
1492 Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, 1492 Capital Management held 115 positions worth $112M, down 27% from $154M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
1492 Capital Management withdrew a net $9.44M in Q4 2018, closing 26 positions and reducing 44 holdings. Its most notable exit was Dycom Industries, an estimated $2.89M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, 1492 Capital Management opened a new position in Collegium Pharmaceutical worth $2.58M.
- 1492 Capital Management's largest Q4 2018 buy was Collegium Pharmaceutical: 150,189 shares worth $2.58M.
- 1492 Capital Management added most to BioDelivery Sciences International, Inc. in Q4 2018, an estimated $1.97M increase.
- 1492 Capital Management's biggest Q4 2018 reduction was BioTelemetry, Inc., cutting an estimated $2.2M.
- 1492 Capital Management fully exited Dycom Industries in Q4 2018, selling an estimated $2.89M.
- 1492 Capital Management's ten largest holdings make up 37% of its $112M portfolio in Q4 2018.
- 1492 Capital Management opened 23 new positions and closed 26 in Q4 2018.
- 1492 Capital Management's portfolio value fell 27% quarter-over-quarter to $112M.
Based on 1492 Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.